Skip to main content
. 2017 Feb 2;8(11):17873–17886. doi: 10.18632/oncotarget.15013

Figure 3. Modulation of neural differentiation in shHes1-CSC by immunofluorescence assay.

Figure 3

(A–C) Immunostaining for Nestin reveals its upregulation in control cells vs Hes1-depleted cells (arrows). (D–F) Immunostaining for MAP2 reveals its upregulation in Hes1-depleted cells vs control cells (arrows). Images were captured at 400X magnification.